Market Analysis, Jgsd Vol: 8 Issue: 2
2nd International Conference on Women’s Health, Reproduction and Fertility scheduled during March 16-17, 2020 at Dubai, UAE
Yousef salameh
An-Najah National University, Palestine, E-mail: Yousefsalameh@gmail.com
Keywords: Genital
Women’s health conference is an approach of prevention and treatment that focuses on health concerns unique to females. Usually, men and women share relative health challenges; the only disparity is that Women’s Health needs specific consideration.
Fertility is the natural capacity to conceive or produce offspring. Infertility affects more than 3 million couples in the United States. About 40% of cases are due to female factors, 30% are due to male factors, 20% are a combination of both, and in about 10 % the cause is unknown. Many lifestyle factors such as the age at which to start a family, nutrition, weight, exercise, psychological stress, environmental and occupational exposures, and others can have substantial effects on fertility.
Fertility treatment typically refers to medications that stimulate egg or sperm production, or procedures that involve the handling of eggs, sperm, or embryos (Assisted Reproductive Technologies). The global fertility services market was esteemed at $16,761 million of 2016 and is evaluated to reach $30,964 million by 2023, enlisting a CAGR of 9.3% from 2017 to 2023.
The recent advancements in infertility were enlightened and discussed in the Reproduction Fertility conference held during April 08-09, 2019 at Dubai, UAE. The initiatives to spread global awareness on women’s health and discuss reproductive disease related information and ideas among people for disease prevention and control were discussed by Christos Tsitlakidis, Consultant Obstetrician and Gynaecologist, Pinderfields Hospital, UK, who discussed on Modifying the caesarean, a contemporary approach, modifying the procedure in several areas came out of necessity to respond to new challenges that appeared over last decades; and Mohammad Ebrahim Parsanezhad, Shiraz University of Medical Sciences, Iran, who enlightened on Management of Clomiphene citrate resistant women with PCOD as nowadays, 1 out of 10 women are diagnosed with PCOS.
Recalling this maxim discussion, we promise to frame the program for the “2nd International Conference on Women’s Health, Reproduction and Fertility” scheduled during March 16-17, 2020 at Dubai, UAE with more splendid presentations and sessions mainly focusing on insights into women’s health and infertility.
References
1. Management of Clomiphene Citrate Resistant Women with PCOD by Mohammad Ebrahim Parsanezhad, Shiraz University of Medical Sciences, Iran.
2. Modifying the Caesarean: A contemporary approach by Christos Tsitlakidis, Pinderfields Hospital, UK.
Leslie Brown
Program Manager | Reproduction Fertility 2020
Send a mail to reproduction@memeetings.com
Phone No.: +1-201-380-5561 ;Extn. 7006
WhatsApp No.: +44 7723584386
